Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | CFO and EVP | February 16, 2024 | February 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date February 16, 2024 · Filed February 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,251 |
Ending reported balance
After 2024-02-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-02-16 · Grant · Acquired 21,980 · Balance 30,428 F1: On February 3, 2021, the reporting person was granted 10,990 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Row 2 · 2024-02-16 · Tax withholding · Disposed 8,177 · Balance 22,251 |
| Common StockSEC Table I · non-derivative | IndirectBy NLR LLC | 90,000 |
Reported balance
Holding disclosure · report date 2024-02-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 90,000 |
| Common StockSEC Table I · non-derivative | IndirectBy BNR LLC | 40,000 |
Reported balance
Holding disclosure · report date 2024-02-16 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 40,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 19,834 |
Reported balance
Holding disclosure · report date 2024-02-16 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 19,834 |
| Common StockSEC Table I · non-derivative | IndirectBy TJR LLC | 10,000 |
Reported balance
Holding disclosure · report date 2024-02-16 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 10,000 |
Filing footnotes · ownership attribution and instrument terms
F1: On February 3, 2021, the reporting person was granted 10,990 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2017 Filed Mar 1, 2017 00:27 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,328 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015513 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:06 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 8,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-014533 · doc4.xml · derivative · entry 4 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2024-02-05 F3 · balance_after: On February 5, 2014, the reporting person was granted 42,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 8,500 stock appreciation rights. Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:06 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 1,700 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-014533 · doc4.xml · derivative · entry 3 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires 2023-02-06 F2 · balance_after: On February 6, 2013, the reporting person was granted 8,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,700 stock appreciation rights. Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:06 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 153 | $85.91 | $13,144.23 |
DisclosureSEC source: 0001209191-17-014533 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,472 Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:06 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 560 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-014533 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,625 F1 · kind: On February 6, 2013, the reporting person was granted 2,800 restricted stock units. The restricted stock units are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the restricted stock units subject to such criteria vested, resulting in the vesting of 560 restricted stock units. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 00:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 229 | $82.67 | $18,931.43 |
DisclosureSEC source: 0001209191-17-008464 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,065 Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 56,850 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007875 · doc4.xml · derivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,850 Underlying: Common Stock · 56,850 shares Expires 2027-02-01 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.